Menlo Park, CA, December 01, 2016 --(PR.com
)-- Life Science Strategy Group, (LSSG) the leading strategic consulting firm to the CRO industry, is pleased to announce the launch of a new report, "Wearable Technology Utilization in Clinical Trials and the Role of CROs: Current and Future Outlook," which focuses on the adoption of wearable technology in clinical trials and perceived preparedness of CROs to incorporate wearable technology into clinical development services. Quantitative research with approximately 130 biopharmaceutical outsourcing decision makers with clinical development responsibilities reveals current implementation levels of wearable technology in clinical trials, satisfaction with wearable technology, benefits, hurdles and future wearable technology needs and implications to the CRO market.
The data, representing input from small, mid-sized and large biopharmaceutical companies globally, indicate that biopharmaceutical companies are not yet fully educated on the rationale for and use of wearable technology in clinical trials, which presents an opportunity to those CROs investing time and resources in the capability.
“The findings are surprising. While many biopharma decision-makers are actively incorporating wearable technology into their clinical trials, a significant portion are not. Furthermore, many do not feel the need to do so. Our research uncovers key challenges limiting wearable technology use, and identifies opportunities for CROs to better serve the biopharmaceutical market,” said Jon Meyer, Life Science Strategy Group’s CRO Industry Practice Leader.
To learn more about LSSG’s new study revealing wearable technology trends and preparedness of leading CROs including Covance, ICON, inVentiv Health Clinical, INC Research, Parexel, PPD, PRA International and QuintilesIMS, please contact Life Science Strategy Group or click on the link below.Wearable Technology Utilization in Clinical Trials and the Role of CROs
About Life Science Strategy Group, LLC
Life Science Strategy Group, LLC specializes in strategic consulting and market research engagements across a variety of therapeutic, technology and service industries including contract research services, pharmaceutical, biotechnology, medical devices, diagnostics and drug discovery.